Search

Showing "11155" results for ""

Therapeutic vaccine plus interleukin-2 shows best viral control in treatment breaks

Pre-exposure prophylaxis may only offer limited benefit

Vanguard treatment programmes pave the way to scale up

Entecavir gains ground as anti-HBV option in HIV-coinfected patients

TMC114 appears to be strong PI option for salvage therapy

Myocardial infarction risk rises with each year of antiretroviral therapy, but remains low

Tipranavir superior to other PIs in detailed resistance analysis

Is less than 95% adherence to NNRTIs good enough to lead to viral suppression?

Two new formulations receive European go-ahead

Fibrosis progression may be faster than expected in HCV/HIV-coinfected patients

Tenofovir at least equivalent to adefovir for treatment of hepatitis B in HIV-infected patients

CDC pioneers family-based "preventive care" in Uganda as framework for rollout

Unusual eye lesions should be warning sign for possibility of HIV, suggests case report

Testing for HIV should no longer be accorded special status, says BMJ editorial

Slow progress on HIV vaccines reported at CROI

'Dear Dr' letter issued about risks of using tenofovir and ddI together

US pressure for UN needle/syringe exchange u-turn 'overrules science', campaigners say in open letter prior to Vienna drugs meeting

US approves Pegasys with ribavirin for chronic HCV in HIV/HCV coinfected adults; adds NRTI warning

Receive the latest HIV research and conference news

Showing "11155" results for ""

Therapeutic vaccine plus interleukin-2 shows best viral control in treatment breaks

Pre-exposure prophylaxis may only offer limited benefit

Vanguard treatment programmes pave the way to scale up

Entecavir gains ground as anti-HBV option in HIV-coinfected patients

TMC114 appears to be strong PI option for salvage therapy

Myocardial infarction risk rises with each year of antiretroviral therapy, but remains low

Tipranavir superior to other PIs in detailed resistance analysis

Is less than 95% adherence to NNRTIs good enough to lead to viral suppression?

Two new formulations receive European go-ahead

Fibrosis progression may be faster than expected in HCV/HIV-coinfected patients

Tenofovir at least equivalent to adefovir for treatment of hepatitis B in HIV-infected patients

CDC pioneers family-based "preventive care" in Uganda as framework for rollout

Unusual eye lesions should be warning sign for possibility of HIV, suggests case report

Testing for HIV should no longer be accorded special status, says BMJ editorial

Slow progress on HIV vaccines reported at CROI

'Dear Dr' letter issued about risks of using tenofovir and ddI together

US pressure for UN needle/syringe exchange u-turn 'overrules science', campaigners say in open letter prior to Vienna drugs meeting

US approves Pegasys with ribavirin for chronic HCV in HIV/HCV coinfected adults; adds NRTI warning

Receive the latest HIV research and conference news